LINCOCIN 100 mg/ml raztopina za injiciranje za prašiče, pse in mačke
LINCOCIN 100 mg/ml raztopina za injiciranje za prašiče, pse in mačke
Not authorised
- Lincomycin hydrochloride
Product identification
Medicine name:
LINCOCIN 100 mg/ml raztopina za injiciranje za prašiče, pse in mačke
Active substance:
- Lincomycin hydrochloride
Target species:
-
Cat
-
Dog
-
Pig
Route of administration:
-
Intravenous use
-
Intramuscular use
Product details
Active substance and strength:
-
Lincomycin hydrochloride100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal2dayMeso in organi prašičev: 2 dni.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Slovenia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Pfizer Manufacturing Belgium
- Zoetis Belgium
Responsible authority:
- Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
- NP/V/0187/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Slovenian (PDF)
Published on: 29/11/2021
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Slovenian (PDF)
Published on: 29/11/2021
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Slovenian (PDF)
Published on: 29/11/2021